We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CBER’s Marks Pushes for Accelerated Approval in Gene Therapies for Rare Diseases
CBER’s Marks Pushes for Accelerated Approval in Gene Therapies for Rare Diseases
Peter Marks, director of CBER, is pushing to get more gene therapies targeting rare diseases to apply for accelerated approval (AA) to give the promising space a leg up in development.